Page 41 - Anna Marriott News Today

“Even if it happens in a couple of pockets in a few countries, it’s not going to protect people across the world.”

The virus will linger if richer countries do not help distribute or sell the vaccine to poorer countries.

Ndubuisi Francis in Abuja A group of campaigning organisations under the aegis of People’s Vaccine Alliance, have warned that nearly 70 countries may be able to vaccinate only one in 10 people against the COVID-19 pandemic as wealthier nations have bought up most of the stock. Their warning is predicated on data indicating the deals already done on the procurement of the vaccines by rich nations. According to the People’s Vaccine Alliance, rich countries with 14 per cent of the world’s po...

BRYAN R. SMITH/AFP via Getty Images The CEO of the The New Jewish Home long-term care facility in New York receives the Pfizer Covid-19 vaccine on December 21, 2020. Wealthier countries like the US and the UK have cleaned out global supplies of coronavirus vaccines, leaving many nations without access to any doses at all. Rich countries have reserved more doses than their populations need, while lower-income countries are relying on a UN-backed acquisition program that may struggle to deliver. ...

Article content Many people, tired of COVID-19 restrictions, are hoping a mass vaccination program could bring an end to the pandemic that has claimed more than 1.6 million lives worldwide. However, “vaccine nationalism” by rich nations buying up future supplies of COVID-19 vaccines has raised questions about equal access by poorer countries. We apologize, but this video has failed to load. Try refreshing your browser. Rich countries hoard COVID-19 vaccine   — MONIN Back t...

Article content Many people, tired of COVID-19 restrictions, are hoping a mass vaccination program could bring an end to the pandemic that has claimed more than 1.6 million lives worldwide. However, “vaccine nationalism” by rich nations buying up future supplies of COVID-19 vaccines has raised questions about equal access by poorer countries. We apologize, but this video has failed to load. Try refreshing your browser. Rich countries hoard COVID-19 vaccine   — MONIN Back t...

Article content Many people, tired of COVID-19 restrictions, are hoping a mass vaccination program could bring an end to the pandemic that has claimed more than 1.6 million lives worldwide. However, “vaccine nationalism” by rich nations buying up future supplies of COVID-19 vaccines has raised questions about equal access by poorer countries. We apologize, but this video has failed to load. Try refreshing your browser. Rich countries hoard COVID-19 vaccine   — MONIN Back t...

Poor nations to miss out on vaccine as West buys most of it: Report By Bhavya Singh|   Updated: 21st December 2020 2:10 pm IST The pandemic has exposed vast inequities both within and between countries. A group of campaigning organisations have warned that nearly 70 countries may be able to vaccinate only one in ten people as wealthier nations have bought up most of the stock.  According to the People’s Vaccine alliance, rich countries with 14% of the world’s population have bought 53% o...

Dont show me this message again✕ Rich Americans in California are offering to buy their way to the front of the coronavirus vaccine line as the state continues to see a surge in infections and deaths, reports have said. Speaking to CNN, a number of concierge doctors in the area say have received a number of requests for early access to the new vaccine in return for premium payments or donations. Dr Jeff Toll, whose boutique internal medicine practice has admitting privileges at Cedars-Sinai M...

Speed read Recent analysis shows no country in Sub-Saharan Africa has such a deal in place Unequal distribution of vaccines could hurt the global fight against the pandemic Share this article: Republish We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines: You have to credit our authors. You have to credit SciDev.Net — where possible include our logo with a link back to the original...